MENU
+Compare
MIRM
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$76.06
Change
+$1.88 (+2.53%)
Capitalization
3.82B

MIRM Mirum Pharmaceuticals Forecast, Technical & Fundamental Analysis

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases... Show more

MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MIRM with price predictions
Sep 05, 2025

Aroon Indicator for MIRM shows an upward move is likely

MIRM's Aroon Indicator triggered a bullish signal on September 05, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 269 similar instances where the Aroon Indicator showed a similar pattern. In of the 269 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MIRM just turned positive on August 07, 2025. Looking at past instances where MIRM's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIRM advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 20 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 20 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIRM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.970) is normal, around the industry mean (20.107). P/E Ratio (0.000) is within average values for comparable stocks, (52.767). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.138). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (8.621) is also within normal values, averaging (327.388).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
MIRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MIRM is expected to report earnings to rise 47.58% to -17 cents per share on November 12

Mirum Pharmaceuticals MIRM Stock Earnings Reports
Q3'25
Est.
$-0.18
Q2'25
Beat
by $0.21
Q1'25
Beat
by $0.01
Q4'24
Missed
by $1.55
Q3'24
Beat
by $0.15
The last earnings report on August 06 showed earnings per share of -11 cents, beating the estimate of -33 cents. With 445.65K shares outstanding, the current market capitalization sits at 3.82B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HACAX125.81N/A
N/A
Harbor Capital Appreciation Instl
HFDRX18.96N/A
N/A
Hartford Schroders US MidCap Opps R3
HNCUX21.17N/A
N/A
Hartford International Growth R6
IAFLX21.28N/A
N/A
F/m Investments Large Cap Focused Inst
JORNX20.57-0.01
-0.05%
Janus Henderson Global Select T

MIRM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with XERS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+2.53%
XERS - MIRM
52%
Loosely correlated
-0.51%
CRNX - MIRM
45%
Loosely correlated
+3.97%
IRON - MIRM
43%
Loosely correlated
+0.95%
RNA - MIRM
42%
Loosely correlated
+3.90%
NRIX - MIRM
42%
Loosely correlated
+8.66%
More